Ion Mobility Revenue and Competitors
Estimated Revenue & Valuation
- Ion Mobility's estimated annual revenue is currently $28.2M per year.
- Ion Mobility's estimated revenue per employee is $328,000
Employee Data
- Ion Mobility has 86 Employees.
- Ion Mobility grew their employee count by 32% last year.
Ion Mobility's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Automotive Systems Engineer | Reveal Email/Phone |
Ion Mobility Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.2M | 65 | -16% | N/A | N/A |
#2 | $6M | 26 | 13% | N/A | N/A |
#3 | $30.8M | 94 | 7% | N/A | N/A |
#4 | $28.2M | 86 | 32% | N/A | N/A |
#5 | $2.6M | 13 | 0% | N/A | N/A |
What Is Ion Mobility?
We are Southeast Asia's leading EV mobility technology startup that is building price-to-performance superior, smart/connected alternatives to gasoline motorcycles in the 110-250cc segment.
keywords:N/A
N/A
Total Funding
86
Number of Employees
$28.2M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ion Mobility News
2022-04-13 - Ion Mobility Mass Spectrometry Phosphopeptide Analysis
Automated phosphopeptide enrichment and ion mobility mass spectrometry (IMS-MS) enables detailed analysis of structural effects of...
2022-03-22 - TU Munich & MIT research improves ion mobility
Lithium-ion batteries and fuel cells depend on good ion mobility, but this faces many obstacles. In the future, this newly discovered opto-...
2022-03-22 - timsTOF MALDI PharmaPulse, a trapped ion mobility-enabled mass ...
timsTOF MALDI PharmaPulse, a trapped ion mobility-enabled mass spec solution for label-free HTS in drug discovery. Supported by: 18 May 2022. 8:00 AM PDT...
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.5M | 86 | 8% | N/A |
#2 | $20.1M | 86 | 6% | N/A |
#3 | $12.5M | 86 | N/A | N/A |
#4 | $12.5M | 86 | 8% | N/A |
#5 | $12.5M | 86 | 28% | N/A |